AVIR.NASDAQAtea Pharmaceuticals, INC
Form 4: Franklin M. Berger Reports Stock Transaction in Atea Pharmaceuticals
Sentiment:
SEC Form 4 Filing
Director Franklin M. Berger reports the conversion of restricted stock units into common stock of Atea Pharmaceuticals.
Summary
- On June 16, 2024, Franklin M. Berger, a director of Atea Pharmaceuticals, Inc. (AVIR), converted 33,150 restricted stock units into common stock.
- The transaction was reported on a Form 4 filed with the SEC on June 18, 2024.
- Following the transaction, Berger directly owns 811,503 shares of Atea Pharmaceuticals common stock.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing reporting a stock transaction, which is neutral in sentiment.
Key Dates
| Date | Description |
|---|---|
| 06/16/2024 | Date of transaction: conversion of restricted stock units to common stock. |
| 06/18/2024 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.